Get Real Time Here
| Open8.190 | Close7.910 |
| Vol / Avg.1.035M / 1.165M | Mkt Cap986.175M |
| Day Range7.790 - 8.390 | 52 Wk Range5.950 - 23.180 |
Relay Therapeutics Stock (NASDAQ:RLAY), Quotes and News Summary
Relay Therapeutics Stock (NASDAQ: RLAY) stock price, news, charts, stock research, profile.
| Open8.190 | Close7.910 |
| Vol / Avg.1.035M / 1.165M | Mkt Cap986.175M |
| Day Range7.790 - 8.390 | 52 Wk Range5.950 - 23.180 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.830 | -0.540 | 0.2900 | ||||
| REV | 25.202M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-08 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Lowers | 33.00 | 19.00 |
| 2023-10-17 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Raises | 30.00 | 33.00 |
| 2023-08-17 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Lowers | 32.00 | 30.00 |
| 2023-08-09 | Oppenheimer | Matthew Biegler | Reiterates | OutperformOutperform | Maintains | - | 33.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RLAY | Relay Therapeutics | -0.74% | 986.2M |
| SNDX | Syndax Pharmaceuticals | 2.12% | 1.2B |
| SAGE | Sage Therapeutics | 0.51% | 1.2B |
| DAWN | Day One Biopharmaceutical | 1.9% | 1B |
| XNCR | Xencor | 0.11% | 1.1B |
How do I buy Relay Therapeutics (RLAY) stock?
You can purchase shares of Relay Therapeutics (NASDAQ: RLAY) through any online brokerage.
Who are Relay Therapeutics's (RLAY) competitors?
Other companies in Relay Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Sage Therapeutics (NASDAQ:SAGE), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR) and Protagonist Therapeutics (NASDAQ:PTGX).
What is the target price for Relay Therapeutics (RLAY) stock?
The latest price target for Relay Therapeutics (NASDAQ: RLAY) was reported by HC Wainwright & Co. on Wednesday, November 8, 2023. The analyst firm set a price target for 19.00 expecting RLAY to rise to within 12 months (a possible 137.49% upside). 18 analyst firms have reported ratings in the last year.
Current Stock Price for Relay Therapeutics (RLAY)?
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $8.0002 last updated Today at November 30, 2023 at 11:32 PM UTC.
Does Relay Therapeutics (RLAY) pay a dividend?
There is no dividend information for Relay Therapeutics.
When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?
Relay Therapeutics’s Q4 earnings are confirmed for Thursday, February 22, 2024.
Is Relay Therapeutics (RLAY) going to split?
There is no upcoming split for Relay Therapeutics.
What sector and industry does Relay Therapeutics (RLAY) operate in?
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.